MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from issuance of
common shares,...
$11,144,467
Proceeds from issuance of
common shares,...
$8,391,027
Proceeds from issuance of
common shares pursuant...
$708,468
Proceeds from issuance of
pre-funded warrants from...
$697,658
Proceeds from exercise of
pre-funded warrants
$3,050
Net cash provided by
financing activities
$20,944,670
Net (decrease)
increase in cash
-$7,174,611
Canceled cashflow
$20,944,670
Accrued liabilities
$7,387,454
Prepaid expenses and
other current assets
-$2,555,126
Share-based compensation
expense
$857,628
Accounts payable
$805,952
Maturity of short-term
investment
$33,051
Net cash used in
operating activities
-$28,118,579
Canceled cashflow
$11,606,160
Net cash used in
investing activities
-$702
Canceled cashflow
$33,051
Net (loss) income
-$39,719,147
Change in fair value of
financial instruments
$5,592
Purchase of short-term
investments
$33,753
Back
Back
Cash Flow
source: myfinsight.com
ProMIS Neurosciences Inc. (PMN)
ProMIS Neurosciences Inc. (PMN)